Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.20.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2020
Stockholders' Equity  
Stockholders' Equity

Note 9 - Stockholders’ Equity

Common Stock

Under the terms of the Second Amended and Restated Founders Agreement, which became effective July 22, 2016, Fortress will receive a grant of shares of our common stock equal to two and one-half percent (2.5%) of the gross amount of any equity or debt financing. In March 2020, the Company issued 31,220 shares of common stock to Fortress, which equaled 2.5% of the gross proceeds of $5.0 million from the sale of shares of common stock under Mustang’s At-the-Market Offering. The Company recorded an expense of approximately $0.1 million in general and administrative expenses related to these shares during the six months ended June 30, 2020.

In June 2020, the Company issued 22,170 shares of common stock to Fortress, which equaled 2.5% of the gross proceeds of $3.0 million from the sale of shares of common stock under Mustang’s At-the-Market Offering. The Company recorded an expense of approximately $0.1 million in general and administrative expenses related to these shares during the six months ended June 30, 2020.

 

In June 2020, the Company issued 286,390 shares of common stock to Fortress, which equaled 2.5% of the gross proceeds of $37.2 million from the sale of shares of common stock, before deducting underwriting discounts and commissions and offering expenses under Mustang’s Public Offering. The Company recorded an expense of approximately $0.9 million in general and administrative expenses related to these shares during the six months ended June 30, 2020.

At-the-Market Offering

On July 13, 2018, the Company filed a shelf registration statement No. 333-226175 on Form S-3, as amended on July 20, 2018 (the “2018 Mustang S-3”), which was declared effective in August 2018. Under the 2018 Mustang S-3, the Company may sell up to a total of $75.0 million of its securities. In connection with the 2018 Mustang S-3, the Company entered into an At-the-Market Issuance Sales Agreement (the “Mustang ATM”) with B. Riley FBR, Inc., Cantor Fitzgerald & Co., National Securities Corporation, and Oppenheimer & Co. Inc. (each an "Agent" and collectively, the “Agents”), relating to the sale of shares of common stock. Under the Mustang ATM, the Company pays the Agents a commission rate of up to 3.0% of the gross proceeds from the sale of any shares of common stock.

On August 16, 2019, the Company filed a shelf registration statement No. 333-233350 on Form S-3, (the “2019 Mustang S-3”), which was declared effective on September 30, 2019. Under the 2019 Mustang S-3, the Company may sell up to a total of $75.0 million of its securities.

During the six months ended June 30, 2020, we issued approximately 2.1 million shares of common stock at an average price of $3.76 per share for gross proceeds of $8.0 million under the Mustang ATM. In connection with these sales, we paid aggregate fees of approximately $0.1 million for net proceeds of approximately $7.9 million. During the six months ended June 30, 2019, Mustang issued approximately 3.5 million shares of common stock at an average price of $6.42 per share for gross proceeds of $22.5 million under the Mustang ATM. In connection with these sales, Mustang paid aggregate fees of approximately $0.5 million for net proceeds of approximately $22.0 million. Pursuant to the Founders Agreement, Mustang issued 53,390 shares of common stock to Fortress at a weighted average price of $3.76 per share for the six months ended June 30, 2020, for the Mustang ATM offering noted above. During the six months ended June 30, 2019, Mustang issued 87,656 shares of common stock to Fortress at a weighted average price of $6.42 per share in connection with the Mustang ATM.

Public Offering of Common Stock

 

On June 11, 2020, we entered into an underwriting agreement (the “Underwriting Agreement”) with Cantor Fitzgerald & Co., as representative of the underwriters named therein (each, an “Underwriter” and collectively with Cantor Fitzgerald & Co., the “Underwriters”).

In connection with the Underwriting Agreement, we issued 10,769,231 shares of common stock (plus a 30-day option to purchase up to an additional 1,615,384 shares of common stock, of which 686,373 were exercised as of June 30, 2020) at a price of $3.25 per share for gross proceeds of approximately $37.2 million, before deducting underwriting discounts and commissions and offering expenses. In connection with the public offering, we paid aggregate fees of approximately $2.3 million for net proceeds of approximately $34.9 million. The shares were sold under our S-3 registrations filed with the Securities and Exchange Commission. The offering closed on June 15, 2020, and the over-allotment closed on June 25, 2020.

 

As of June 30, 2020, approximately $50.6 million of the 2019 Mustang S-3 remains available for sales of securities. Mustang may offer the securities under the 2019 Mustang S-3 from time to time in response to market conditions or other circumstances if it believes such a plan of financing is in the best interests of its stockholders. As of June 30, 2020, the 2018 Mustang S-3 is no longer available for sales of securities.

Stock Awards

The Company has in effect the 2016 Incentive Plan (the “Incentive Plan”). The Incentive Plan was adopted in 2016 by our stockholders and the compensation committee of the Company’s board of directors and is authorized to grant stock-based awards to directors, officers, employees and consultants. The plan initially authorized grants to issue up to 2,000,000 shares of authorized but unissued common stock, expires 10 years from adoption, and limits the term of each option to no more than 10 years from the date of grant. In June 2018, the Company’s stockholders approved an amendment to the Incentive Plan to increase the number of authorized shares issuable by 3,000,000 shares, for a total of 5,000,000 shares. Total shares available for the issuance of stock-based awards under the Incentive Plan was 1,324,765 shares at June 30, 2020.

Stock Options

The following table summarizes stock option activities for the six months ended June 30, 2020:

    

    

    

Weighted Average

Remaining

Weighted Average

Contractual Life (in

Stock Options

Exercise Price

years)

Outstanding at December 31, 2019

 

1,241,675

$

5.73

 

7.31

Options forfeited

 

(100,000)

 

5.73

 

Outstanding at June 30, 2020

 

1,141,675

 

5.73

 

6.81

Options vested and exercisable at June 30, 2020

 

428,127

$

5.73

 

6.81

As of June 30, 2020, the Company had unrecognized stock-based compensation expense related to options of $0.3 million, which is expected to be recognized over the remaining weighted average vesting period of approximately 1.0 years.

Restricted Stock

The following table summarizes restricted stock award activities for the six months ended June 30, 2020:

    

    

Weighted Average

Grant Date Fair

Number of Shares

Value

Nonvested at December 31, 2019

 

299,060

$

5.66

Vested

(80,001)

5.73

Nonvested at June 30, 2020

 

219,059

$

5.63

As of June 30, 2020, the Company had unrecognized stock-based compensation expense related to restricted stock of $0.5 million, which is expected to be recognized over the remaining weighted average vesting period of approximately 2.0 years.

Restricted Stock Units

Certain employees and consultants have been awarded restricted stock units with time-based vesting. The following table summarizes restricted stock units’ activities for the six months ended June 30, 2020:

    

    

Weighted Average

Grant Date Fair

Number of Units

Value

Nonvested at December 31, 2019

 

1,112,417

$

5.11

Granted

 

642,500

 

2.73

Forfeited

(36,250)

3.58

Vested

 

(219,439)

 

5.21

Nonvested at December 31, 2020

 

1,499,228

$

4.11

As of June 30, 2020, the Company had unrecognized stock-based compensation expense related to restricted stock units of approximately $3.1 million, which is expected to be recognized over the remaining weighted average vesting period of approximately 1.9 years.

The following table summarizes stock-based compensation expense for the three and six months ended June 30, 2020 and 2019 (in thousands).

For the three months ended June 30, 

For the six months ended June 30, 

    

2020

    

2019

    

2020

    

2019

General and administrative

$

513

$

333

$

865

$

669

Research and development

 

444

 

289

 

897

 

385

Total stock-based compensation expense

$

957

$

622

$

1,762

$

1,054

Employee Stock Purchase Plan

Eligible employees can purchase the Company’s Common Stock at the end of a predetermined offering period at 85% of the lower of the fair market value at the beginning or end of the offering period.  The Employee Stock Purchase Plan (“ESPP”) is compensatory and results in stock-based compensation expense.

For the three and six months ended June 30, 2020, 68,351 shares have been purchased and 341,649 shares are available for future sale under the Company’s ESPP.  The Company recognized share-based compensation expense of $0.2 million for the six months ended June 30, 2020.

Warrants

A summary of warrant activities for six months ended June 30, 2020 is presented below:

    

    

    

Weighted Average

Remaining

Weighted Average

Contractual Life (in

Warrants

Exercise Price

years)

Outstanding as of December 31, 2019

 

5,405,669

$

8.20

 

2.40

Cashless exercised

 

(2,999)

 

 

Outstanding as of December 31, 2020

 

5,402,670

$

8.21

 

1.89

Upon the cashless exercise of warrants, the Company will issue new shares of common stock.